The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease

Journal of Neuroscience Methods

Volumn 177, Issue 2, 2009, Pages 317-321

  Silvestrin, Roberta Bristot ^a   de Oliveira, Lucas Fürstenau ^b   Batassini, Cristiane ^a   Oliveira, Alcyr ^c   e Souza, Tadeu Mello ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Complexo de Ensino Superior de Cachoeirinha ^*  (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

6 Hydroxydopamine; Footfault; Parkinson; Rat; Screening

Indexed keywords

APOMORPHINE; METHYLPHENIDATE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARATUS; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MODEL; FOOTFAULT TEST; GOLD STANDARD; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MOTOR PERFORMANCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD BEHAVIOR; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SCREENING TEST; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; BEHAVIORAL SCIENCES; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DRUG EVALUATION, PRECLINICAL; GAIT; GAIT DISORDERS, NEUROLOGIC; MALE; NERVE DEGENERATION; NEURONS; NEUROPHARMACOLOGY; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

EID: 58149512086     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2008.10.030     Document Type: Article

References (20)

1. Castaneda E., Fleming S., Paquette M.A., Boat K., Moffett J., Stachowiak E.K., Bloom D.C., and Stachowiak M.K. Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate. Physiol Behav 84 (2005) 525-535
2. Chopin P., Colpaert F.C., and Marien M. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther 288 (1999) 798-804
3. Costall B., Marsden C.D., Naylor R.J., and Pycock C.J. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Res 118 (1976) 87-113
4. Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175 (2002) 303-317
5. Dunnett S.B., and Iversen S.D. Spontaneous and drug-induced rotation following localized 6-hydroxydopamine and kainic acid-induced lesions of the neostriatum. Neuropharmacology 21 (1982) 899-908
6. Hefti F., Melamed E., and Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res 195 (1980) 123-137
7. Hernandez T.D., and Schallert T. Seizures and recovery from experimental brain damage. Exp Neurol 102 (1988) 318-324
8. Himes B.T., Neuhuber B., Coleman C., Kushner R., Swanger S.A., Kopen G.C., Wagner J., Shumsky J.S., and Fischer I. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair 20 (2006) 278-296
9. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68 (1997) 2032-2037
10. Lubics A., Reglodi D., Tamas A., Kiss P., Szalai M., Szalontay L., and Lengvari I. Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res 157 (2005) 157-165
11. Matsuda H., Akechi Y., Shimada Y., Terasawa K., and Watanabe H. Relationship of the ipsilateral rotation in night period and striatal dopamine content reduction in unilateral nigrostriatal 6-OHDA lesioned rats. Brain Res 686 (1995) 111-114
12. Metz G.A., Tse A., Ballermann M., Smith L.K., and Fouad K. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis. Eur J Neurosci 22 (2005) 735-744
13. Modo M., Stroemer R.P., Tang E., Veizovic T., Sowniski P., and Hodges H. Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J Neurosci Methods 104 (2000) 99-109
14. Morelli M., Fenu S., Garau L., and Di Chiara G. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162 (1989) 329-335
15. Pitsikas N., Brambilla A., Besozzi C., Bonali P., Fodritto F., Grippa N., Scandroglio A., and Borsini F. Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia. Pharmacol Biochem Behav 68 (2001) 443-447
16. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 (1996) 275-331
17. Simola N., Morelli M., and Carta A.R. The 6-hydroxydopamine model of Parkinson's disease. Neurotox Res 11 (2007) 151-167
18. Starkey M.L., Barritt A.W., Yip P.K., Davies M., Hamers F.P., McMahon S.B., and Bradbury E.J. Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice. Exp Neurol 195 (2005) 524-539
19. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24 (1970) 485-493
20. Yuan H., Sarre S., Ebinger G., and Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J Neurosci Methods 144 (2005) 35-45